{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T21:09:20Z","timestamp":1764364160884},"reference-count":26,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.05.034","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T09:01:33Z","timestamp":1400490093000},"page":"3942-3949","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years"],"prefix":"10.1016","volume":"32","author":[{"given":"Rolf","family":"Dominicus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Galtier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Richard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2014.05.034_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1586\/erv.10.27","article-title":"Updated vaccine guidelines for aging and aged citizens of Europe","volume":"9","author":"Michel","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/REVEH.2005.20.4.303","article-title":"Environmentally and occupationally acquired diseases in adolescents and adulthood: control of diphtheria, tetanus, pertussis, and poliomyelitis through regular booster vaccinations \u2013 a European perspective","volume":"20","author":"Hofmann","year":"2005","journal-title":"Rev Environ Health"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0015","first-page":"13","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF03324906","article-title":"Educational vaccine tools: the French initiative","volume":"21","author":"Belmin","year":"2009","journal-title":"Aging Clin Exp Res"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.05.034_bib0025","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1086\/315534","article-title":"Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned","volume":"181","author":"Dittmann","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0030","series-title":"The expanded programme on immunization in the European region of WHO: Diphtheria: Manual for management and control of diphtheria in the European region","author":"Begg","year":"1994"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/978-0-387-73960-1_7","article-title":"Pertussis immunisation in adolescents and adults","volume":"609","author":"Heininger","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","article-title":"Infant pertussis: who was the source?","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.inf.0000258699.64164.6d","article-title":"Transmission of Bordetella pertussis to young infants","volume":"26","author":"Wendelboe","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0050","first-page":"1302","article-title":"Tetanus and pertussis vaccination coverage among adults aged >18 years \u2013 United States, 1999 and 2008","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0055","series-title":"Annual Epidemiological Report. Reporting on 2010 surveillance data and 2011 epidemic intelligence data","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2013"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0060","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1185\/03007X233034","article-title":"Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines","volume":"23","author":"Theeten","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"April","key":"10.1016\/j.vaccine.2014.05.034_bib0065","first-page":"129","article-title":"Le Calendrier des vaccinations et les recommandations vaccinales 2013 selon l\u2019avis du Haut Conseil de la sant\u00e9 publique","volume":"2013","author":"Institut De Veille Santaire","year":"2013","journal-title":"Bull Epidemiol Hebd"},{"issue":"July","key":"10.1016\/j.vaccine.2014.05.034_bib0070","first-page":"283","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand","volume":"30","author":"Mitteilung der St\u00e4ndigen Impfkommission am Robert Koch-Institut (RKI)","year":"2012","journal-title":"Epidemiol Bull"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0075","series-title":"Repevax\u00ae Summary of Product Characteristics","author":"Sanofi Pasteur","year":"2012"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0080","series-title":"Revaxis\u00ae Summary of Product Characteristics","author":"Sanofi Pasteur","year":"2008"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1128\/CVI.05460-11","article-title":"Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays","volume":"19","author":"Kapasi","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0090","series-title":"The immunological basis for immunization series. Module 2: diphtheria update","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0095","series-title":"The immunological basis for immunization series. Module 2: diphtheria update","author":"World Health Organization","year":"1993"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0100","series-title":"The immunological basis for immunization series. Module 3: tetanus update","author":"World Health Organization","year":"2006"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0105","series-title":"The immunological basis for immunization series. Module 6: poliomyelitis","author":"World Health Organization","year":"1993"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.inf.0000177282.53500.77","article-title":"Resurgence of pertussis in Europe","volume":"24","author":"Celentano","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4161\/hv.6.10.12582","article-title":"Humoral immunity of dTap-IPV vaccine (REPEVAX(R)) administered one month after dT-IPV vaccine (REVAXIS(R)) in adults with unknown vaccination history","volume":"6","author":"Larnaudie","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0120","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.vaccine.2006.06.037","article-title":"Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers","volume":"24","author":"Kaml","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1099\/00222615-25-4-279","article-title":"Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test","volume":"25","author":"Melville-Smith","year":"1988","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2014.05.034_bib0130","series-title":"Plan de vaccination suisse","author":"Infovac","year":"2013"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14007014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T03:28:49Z","timestamp":1538623729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14007014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":26,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14007014"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax\u00ae) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis\u00ae) in adults aged \u226540 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}